MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Medinotec Inc. revenue by segment
By business segment
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outside The United States [Member] | $9.50M | $9.12M | $10.86M | $10.80M | $9.34M | $8.44M | $7.22M | $6.74M | $5.34M | $4.47M | – | – | 92.8% | +1.8% |
| Outside U S A Distribution Agreement Sales [Member] | $8.49M | $8.14M | $9.67M | $9.71M | $8.28M | $7.57M | $6.02M | $5.17M | – | $3.49M | – | – | 82.9% | +2.6% |
| Outside U S A Internally Designed Manufactured Sales [Member] | $1.01M | $975.97K | $1.19M | $1.09M | $1.06M | $863.34K | – | – | – | – | $1.27M | $1.13M | 9.9% | -4.5% |
| Inside The United States [Member] | $741.89K | $611.86K | $571.40K | $660.47K | $692.40K | $678.11K | $652.14K | $568.43K | $514.82K | $553.97K | – | – | 7.2% | +7.1% |
| Inside U S A Internally Designed Manufactured Sales [Member] | $741.89K | $611.86K | $571.40K | $660.47K | $692.40K | $678.11K | $652.14K | $568.43K | $514.82K | $553.97K | – | – | 7.2% | +7.1% |
| Operating income | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outside The United States [Member] | $1.30M | $1.66M | $3.90M | $4.02M | $3.72M | $3.44M | $1.68M | $1.27M | $889.42K | $602.16K | – | – | -65.0% |
| Inside The United States [Member] | -$303.86K | -$560.61K | -$578.50K | -$725.86K | -$517.98K | -$251.20K | -$200.16K | -$63.02K | -$60.53K | -$1.58K | – | – | -41.3% |
By product or service
By region
From the segment and revenue-disaggregation notes of Medinotec's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.